[Federal Register Volume 72, Number 109 (Thursday, June 7, 2007)]
[Notices]
[Pages 31587-31588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-2829]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2007N-0208]


Science Board to the Food and Drug Administration; Amendment of 
Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Science Board to the Food and Drug 
Administration (Science Board). This meeting was originally announced 
in the Federal Register of May 21, 2007 (72 FR 28499). The amendment is 
being made to reflect a change in the Agenda and Procedure portions of 
the document. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Carlos Pe[ntilde]a, Office of the 
Commissioner, Food and Drug Administration (HF-33), 5600 Fishers Lane, 
Rockville, Maryland, 20857, 301-827-6687, 
carlos.pe[ntilde][email protected], or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512603. Please call the Information Line for up-to-date information 
on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of May 21, 2007, FDA 
announced that a meeting of the Science Board would be held on June 14, 
2007. On page 28499, in the second and third columns, the Agenda and 
Procedure portions of document are amended to read as follows:
    Agenda: The Science Board will hear about and discuss the agency's 
bioinformatics initiative and fellowship program. The Science Board 
will hear about and review the scientific validity of the agency's 
``Interim Melamine and Analogues Safety/Risk Assessment'' (http://
www.cfsan.fda.gov/~lrd/fr070530.html, Docket No. 2007N-0208). The 
Science Board will then continue its discussion of the review of both 
the agency's science programs and the National Antimicrobial Resistance 
Monitoring System (NARMS) Program, from the March 31, 2006, Science 
Board meeting. Discussions will first include a

[[Page 31588]]

subcommittee update to the Science Board on the progress of the review 
of the agency's science programs. The Science Board will then hear 
about and discuss the subcommittee review of the NARMS Program 
including the public meeting regarding the NARMS Program on April 10, 
2007, and subsequent deliberations.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. We 
are extending the written submission deadline based upon the amended 
Federal Register notice. Written submissions may be made to the contact 
person on or before June 9, 2007. Two oral presentations from the 
public will be scheduled between approximately 10:45 a.m. and 11:45 
p.m., and 3:15 p.m. and 4:15 p.m. Those desiring to make formal oral 
presentations should notify the contact person and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their presentation 
on or before June 9, 2007. Time allotted for each presentation may be 
limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open public hearing sessions. The contact person will 
notify interested persons regarding their request to speak by June 9, 
2007.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app.2) and 21 CFR part 14, relating to the advisory committees.

    Dated: June 1, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. 07-2829 Filed 6-4-07; 11:10 am]
BILLING CODE 4160-01-S